Statistical analysis indicated that none of the tested factors (age, gender, presence of hypertension, diabetes mellitus, renal dysfunction, ischemic heart disease or number of diagnosis) were significantly associated with use of an optimal dose of an ACE inhibitor, and thus no valid model could be built to predict the use of an optimal dose. Here, ACE is linked to hypertensive disorder.